Abstract
IntroductionBiologic therapies have an ever-increasing evidence base to support their use in treatment of inflammatory bowel disease (IBD). Increasing number of patients on such treatments coupled with reduction in outpatient...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
